OPNT
OPIANT PHARMACEUTICALS, INC.
Total Trades
32
Buys
5
Sells
27
Largest Trade
$100K–$500K
Insiders
10
Institutional Funds
1
Inst. Value
$100K–$500K
Activist Filings
4
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| CRYSTAL ROGER | CEO | SELL | $15K–$50K | 1K | $20.26 | Jan 31, 2023 |
| Ellison Mark Jason Heath | Chief Development … | SELL | $1K–$15K | 610 | $20.26 | Jan 31, 2023 |
| Gorman Brian | Insider | SELL | $1K–$15K | 444 | $20.26 | Jan 31, 2023 |
| Skolnick Phil | Chief Scientific O… | SELL | $1K–$15K | 480 | $20.26 | Jan 31, 2023 |
| O'Toole David D | CFO | SELL | $1K–$15K | 541 | $20.26 | Jan 31, 2023 |
| O'Toole David D | CFO | SELL | $1K–$15K | 415 | $20.20 | Jan 9, 2023 |
| Ellison Mark Jason Heath | Chief Development … | SELL | $1K–$15K | 469 | $20.20 | Jan 9, 2023 |
| Skolnick Phil | Chief Scientific O… | SELL | $1K–$15K | 369 | $20.20 | Jan 9, 2023 |
| CRYSTAL ROGER | CEO | SELL | $15K–$50K | 1K | $20.20 | Jan 9, 2023 |
| Ellison Mark Jason Heath | Chief Development … | SELL | $15K–$50K | 2K | $20.20 | Jan 5, 2023 |
| O'Toole David D | CFO | SELL | $15K–$50K | 2K | $20.20 | Jan 5, 2023 |
| Gorman Brian | Insider | SELL | $15K–$50K | 1K | $20.20 | Jan 5, 2023 |
| Skolnick Phil | Chief Scientific O… | SELL | $15K–$50K | 1K | $20.20 | Jan 5, 2023 |
| CRYSTAL ROGER | CEO | SELL | $100K–$500K | 5K | $20.20 | Jan 5, 2023 |
| Ruth Matthew R. | Chief Commercial O… | SELL | $1K–$15K | 1K | $10.62 | Jul 21, 2022 |
| O'Toole David D | CFO | SELL | $1K–$15K | 779 | $11.10 | Jul 15, 2022 |
| Skolnick Phil | Chief Scientific O… | SELL | $1K–$15K | 627 | $11.85 | Jul 15, 2022 |
| Gorman Brian | Insider | SELL | $1K–$15K | 691 | $11.16 | Jul 15, 2022 |
| CRYSTAL ROGER | CEO | SELL | $15K–$50K | 2K | $11.11 | Jul 15, 2022 |
| Sinclair Michael | Director | SELL | $100K–$500K | 14K | $10.96 | Jun 15, 2022 |
| Collard Craig A | Director | BUY | $50K–$100K | 6K | $11.10 | Jun 13, 2022 |
| Sinclair Michael | Director | SELL | $50K–$100K | 8K | $12.25 | Jun 13, 2022 |
| Sinclair Michael | Director | SELL | $100K–$500K | 8K | $12.93 | Jun 8, 2022 |
| Silver Gabrielle Alison | Director | BUY | $15K–$50K | 3K | $13.29 | May 17, 2022 |
| Collard Craig A | Director | BUY | $100K–$500K | 27K | $13.54 | May 17, 2022 |
| Collard Craig A | Director | BUY | $15K–$50K | 4K | $10.49 | May 16, 2022 |
| MacDougall Ann L. | Director | BUY | $15K–$50K | 3K | $10.93 | May 16, 2022 |
| Skolnick Phil | Chief Scientific O… | SELL | $15K–$50K | 2K | $26.19 | Jan 27, 2022 |
| CRYSTAL ROGER | CEO | SELL | $50K–$100K | 2K | $26.15 | Jan 27, 2022 |
| O'Toole David D | CFO | SELL | $1K–$15K | 432 | $30.60 | Jan 12, 2022 |
| Skolnick Phil | Chief Scientific O… | SELL | $1K–$15K | 385 | $30.49 | Jan 12, 2022 |
| CRYSTAL ROGER | CEO | SELL | $15K–$50K | 1K | $30.49 | Jan 12, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Sep 30, 2022 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| STATE STREET CORP | 13K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Jun 17, 2022
11.2%
637K shares
SC 13D/A · Jun 17, 2022
9.3%
515K shares
Renaissance Technologies LLC 26-0385758
SC 13G/A · Feb 11, 2022
3.9%
184K shares
Wells Fargo & Company (b) Tax ID 41-0449260
SC 13G/A · Jan 27, 2022
4.8%
224K shares